Seems like an extremly serious loss for CNDO. Aside from the innocuous "to pursue other interests" has
anyone heard any rumors regarding the "real" reason for Sandage's departure? To leave the company at this
time seems a bit hasty if everything is going to plan.....buyout anyone?
I am guessing he was already pretty much minimized when Harlan Weisman replaced him as CEO some time ago. At the time, the stock jumped 5% or so, for obvious reasons, in that Weisman has already proven himself to be a major player, bringing Remicade to market with JNJ. I could be wrong but not sure if Sandage title was much more than an honarary title prior to him stepping down.